Main
>
ONCOLOGY (**)
>
Lung>NSCLC>Stage III>MET>PD-L1+>>
>
TREAT.:
>
Co: USA. M. PembrolizuMAb
>
(*) USA Approval Date: 2019. 04.11.
(*) USA Approval Date: 2019. 04.11.'s products
This section has no products